Bioterrorism Product Research Tax Credit Expanded Under Lieberman Bill
Executive Summary
Bioterrorism product research tax credits would be expanded to include companies with tax liability, such as larger biotech and pharma firms, under reworked legislation being developed by Sen. Joseph Lieberman (D-Conn.)
You may also be interested in...
Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says
Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report
Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says
Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report
Patent Incentive For Bioterrorism Research Offered In Lieberman Bill
Pharmaceuticals approved for use as anti-bioterrorism agents would be eligible for full patent term restoration under legislation introduced by Sen. Joe Lieberman (D-Conn.) on Dec. 4